Alexandra Kropotova
Vermögen: 155 275 $ am 31.08.2026
Vermögen: 155 275 $ am 31.08.2026
Dr. Alexandra Kropotova is a Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. and an Independent Director at iBio, Inc. She is on the Board of Directors at iBio, Inc. Dr. Kropotova was previously employed as a VP-Global Specialty Research & Development by Teva Pharmaceuticals, Inc., a Vice President-Strategy & Head-Strategic Planning by Sanofi, and a Director & Head-Global Clinical Respiratory by Pfizer Inc. She received her MBA from Ohio University Graduate College and a doctorate degree from Pacific State Medical University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.09.2026 | 41.853 ( 0,05 % ) | 155 275 $ | 31.08.2026 | |
IBIO, INC. -.--% | 01.09.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IBIO, INC. | Direktor/Vorstandsmitglied | 14.10.2020 |
| SAB BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.06.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01.06.2022 |
| SANOFI | Corporate Officer/Principal | 01.01.2016 |
| PFIZER INC. | Direktor/Vorstandsmitglied | 01.01.2007 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Ohio University Graduate College
Ohio University Graduate College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen